Deficiency and abnormalities in Mfn2 expression underlie the pathogenesis of non-alcoholic fatty liver disease (NAFLD), T2DM, diabetic nephropathy, and Charcot–Marie–Tooth disease type 2A (CMT2A) by loss of MAM integrity [43, 44]. Here, MFN2 is linked to diabetic kidney disease.